NUCLEAR MEDICINE AND BIOLOGY

NUCLEAR MEDICINE AND BIOLOGY期刊基本信息

NUCLEAR MEDICINE AND BIOLOGY
  • 简称:NUCL MED BIOL
  • 大类:医学
  • 小类:核医学
  • ISSN:0969-8051
  • IF值:2.492
  • 周期:Bimonthly
  • 是否SCI:SCI/SCIE
  • 是否OA:No
  • 出版地:UNITED STATES
  • 年文章数:94
  • 审稿速度:一般,3-8周
  • 平均录用比例:容易
投稿咨询

官方网站:http://www.journals.elsevier.com/nuclear-medicine-and-biology/

投稿网址:http://ees.elsevier.com/nucmedbio/default.asp?pg=preRegistration.asp

PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0969-8051%5BISSN%5D

NUCLEAR MEDICINE AND BIOLOGY中文简介

核医学和生物学旨在为描述原始合成、体外组织研究或体内使用放射性示踪剂、放射性药物或治疗剂的原始研究贡献。论文集中于合成、体外试验和体内化合物的检测。广泛的研究证明了在体内定位的机制,无论是基于受体,酶,或肿瘤抗原结合或其他明确定义的过程是每一个评估的一个组成部分。此外,研究应确定一个重要的化合物,是一个敏感的探针的生化变化在体内。

NUCLEAR MEDICINE AND BIOLOGY英文简介

Nuclear Medicine and Biology is intended for original research contributions describing original synthesis, in vitro tissue studies, or in vivo use of radiotracers, radiopharmaceuticals, or therapeutic agents. Papers concentrate on the synthesis, testing in vitro, and examination of a compound in vivo. Extensive studies proving the mechanism of localization in vivo whether the radioactive substance is based on receptor-, enzyme-, or tumor antigen-binding or other well defined processes are an integral part of each evaluation. Additionally, studies should define a significant compound that is a sensitive probe of a biochemical change in vivo.

国际期刊推选 论文翻润预审发表!

选择丰富服务快速通过率高一键快速领取私人专属发表方案!

* 请认真填写需求信息,学术顾问24小时内与您取得联系。